全文获取类型
收费全文 | 6698篇 |
免费 | 344篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 264篇 |
妇产科学 | 42篇 |
基础医学 | 918篇 |
口腔科学 | 100篇 |
临床医学 | 340篇 |
内科学 | 1905篇 |
皮肤病学 | 318篇 |
神经病学 | 440篇 |
特种医学 | 311篇 |
外科学 | 1145篇 |
综合类 | 28篇 |
预防医学 | 190篇 |
眼科学 | 147篇 |
药学 | 351篇 |
中国医学 | 14篇 |
肿瘤学 | 561篇 |
出版年
2023年 | 43篇 |
2022年 | 38篇 |
2021年 | 127篇 |
2020年 | 86篇 |
2019年 | 109篇 |
2018年 | 135篇 |
2017年 | 110篇 |
2016年 | 126篇 |
2015年 | 149篇 |
2014年 | 187篇 |
2013年 | 251篇 |
2012年 | 402篇 |
2011年 | 428篇 |
2010年 | 253篇 |
2009年 | 217篇 |
2008年 | 399篇 |
2007年 | 442篇 |
2006年 | 379篇 |
2005年 | 477篇 |
2004年 | 495篇 |
2003年 | 504篇 |
2002年 | 515篇 |
2001年 | 70篇 |
2000年 | 67篇 |
1999年 | 94篇 |
1998年 | 108篇 |
1997年 | 81篇 |
1996年 | 102篇 |
1995年 | 80篇 |
1994年 | 77篇 |
1993年 | 58篇 |
1992年 | 47篇 |
1991年 | 40篇 |
1990年 | 51篇 |
1989年 | 32篇 |
1988年 | 32篇 |
1987年 | 29篇 |
1986年 | 21篇 |
1985年 | 22篇 |
1984年 | 29篇 |
1983年 | 25篇 |
1982年 | 19篇 |
1981年 | 28篇 |
1980年 | 22篇 |
1979年 | 14篇 |
1978年 | 19篇 |
1977年 | 12篇 |
1973年 | 6篇 |
1970年 | 7篇 |
1969年 | 6篇 |
排序方式: 共有7111条查询结果,搜索用时 14 毫秒
1.
Thomas Fuchs-Buder Sorin J. Brull Malin Jonsson Fagerlund J. Ross Renew Guy Cammu Glenn S. Murphy Michiel Warlé Matias Vested Béla Fülesdi Reka Nemes Malachy O. Columb Daniela Damian Peter J. Davis Hajime Iwasaki Lars I. Eriksson 《Acta anaesthesiologica Scandinavica》2023,67(8):994-1017
The set of guidelines for good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents was developed following an international consensus conference in Copenhagen in 1996 (Viby-Mogensen et al., Acta Anaesthesiol Scand 1996, 40 , 59–74); the guidelines were later revised and updated following the second consensus conference in Stockholm in 2005 (Fuchs-Buder et al., Acta Anaesthesiol Scand 2007, 51 , 789–808). In view of new devices and further development of monitoring technologies that emerged since then, (e.g., electromyography, three-dimensional acceleromyography, kinemyography) as well as novel compounds (e.g., sugammadex) a review and update of these recommendations became necessary. The intent of these revised guidelines is to continue to help clinical researchers to conduct high-quality work and advance the field by enhancing the standards, consistency, and comparability of clinical studies. There is growing awareness of the importance of consensus-based reporting standards in clinical trials and observational studies. Such global initiatives are necessary in order to minimize heterogeneous and inadequate data reporting and to improve clarity and comparability between different studies and study cohorts. Variations in definitions of endpoints or outcome variables can introduce confusion and difficulties in interpretation of data, but more importantly, it may preclude building of an adequate body of evidence to achieve reliable conclusions and recommendations. Clinical research in neuromuscular pharmacology and physiology is no exception. 相似文献
2.
3.
4.
5.
6.
7.
8.
Gen Hamanaka Tomoya Kubo Ryo Ohtomo Hajime Takase Estefania Reyes-Bricio Shuntaro Oribe Noriko Osumi Josephine Lok Eng H. Lo Ken Arai 《Glia》2020,68(7):1435-1444
Upon infection or brain damage, microglia are activated to play roles in immune responses, including phagocytosis and soluble factor release. However, little is known whether the event of phagocytosis could be a trigger for releasing soluble factors from microglia. In this study, we tested if microglia secrete a neurovascular mediator matrix metalloproteinase-9 (MMP-9) after phagocytosis in vitro. Primary microglial cultures were prepared from neonatal rat brains. Cultured microglia phagocytosed Escherichia coli bioparticles within 2 hr after incubation and started to secrete MMP-9 at around 12 hr after the phagocytosis. A TLR4 inhibitor TAK242 suppressed the E. coli-bioparticle-induced MMP-9 secretion. However, TAK242 did not change the engulfment of E. coli bioparticles in microglial cultures. Because lipopolysaccharides (LPS), the major component of the outer membrane of E. coli, also induced MMP-9 secretion in a dose–response manner and because the response was inhibited by TAK242 treatment, we assumed that the LPS-TLR4 pathway, which was activated by adhering to the substance, but not through the engulfing process of phagocytosis, would play a role in releasing MMP-9 from microglia after E. coli bioparticle treatment. To support the finding that the engulfing step would not be a critical trigger for MMP-9 secretion after the event of phagocytosis in microglia, we confirmed that cell debris and amyloid beta were both captured into microglia via phagocytosis, but neither of them induced MMP-9 secretion from microglia. Taken together, these data demonstrate that microglial response in MMP-9 secretion after phagocytosis differs depending on the types of particles/substances that microglia encountered. 相似文献
9.